This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Suven Life Sciences Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Durga Malleshwari Kancharla: Innovator in Pharmaceutical Science
Introduction
Durga Malleshwari Kancharla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that act as positive allosteric modulators for muscarinic receptors.
Latest Patents
Durga Malleshwari Kancharla holds a patent for "Polycyclic amides as muscarinic M1 receptor positive allosteric modulators." This invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers, or pharmaceutically acceptable salts thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The patent describes the preparation, pharmaceutical composition, and use of the compound formula (I). He has 1 patent to his name.
Career Highlights
Durga Malleshwari Kancharla is currently associated with Suven Life Sciences Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company.
Collaborations
He has collaborated with notable colleagues such as Ramakrishna Nirogi and Abdul Rasheed Mohammed, contributing to various projects within the pharmaceutical domain.
Conclusion
Durga Malleshwari Kancharla's work exemplifies the spirit of innovation in pharmaceutical science. His contributions, particularly in the area of muscarinic receptor modulation, highlight the importance of research and development in creating effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile